Taveras Arthur
SEC CIK 1830901 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | CSO | 388.0K | — | $120.8K | 10 | 2022-02-11 | 2024-10-07 |
Most active insiders at XFOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| 2 | KIRSKE DAVID | CFO | — | $109.2K |
| 3 | Volpone John | Pres | — | $109.2K |
Taveras Arthur made no open-market trades at XFOR in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-08 | 2024-10-07 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $0.56 | -76.9K | 388.0K | -17% | -$43.1K | |
| 2024-10-08 | 2024-10-04 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | A - Grant | $0.00 | +230.6K | 464.9K | +98% | $0 | |
| 2024-03-11 | 2024-03-11 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $0.88 | -14.2K | 234.3K | -6% | -$12.5K | |
| 2024-02-12 | 2024-02-12 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $1.01 | -787 | 248.5K | -0.3% | -$794.87 | |
| 2023-11-03 | 2023-11-01 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $0.73 | -67.7K | 249.3K | -21% | -$49.4K | |
| 2023-11-02 | 2023-10-31 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | A - Grant | $0.00 | +230.6K | 317.0K | +267% | $0 | |
| 2023-03-13 | 2023-03-10 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $0.84 | -16.8K | 86.4K | -16% | -$14.1K | |
| 2023-02-15 | 2023-02-13 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | S - Sale | $0.93 | -928 | 103.2K | -0.9% | -$863.04 | |
| 2022-03-01 | 2022-03-01 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | A - Grant | $0.00 | +97.0K | 104.1K | +1,365% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | CSO | F - Tax | $0.00 | -928 | 7,107 | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations